Tech Company Financing Transactions
CeraPedics Funding Round
Oxford Finance participated in a $20 million funding round for CeraPedics. The financing round closed on 4/21/2017.
Transaction Overview
Company Name
Announced On
4/21/2017
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Investors
Oxford Finance (Christopher Herr)
Proceeds Purpose
Loan proceeds are being used to support the ongoing commercialization of i-FACTOR's use in cervical spine procedures and help fund a FDA study on its application in Transforaminal Lumbar Interbody Fusion (TLIF.)
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
11025 Dover St. 1600
Westminster, CO 80021
USA
Westminster, CO 80021
USA
Phone
Website
Email Address
Overview
At Cerapedics, we are focused on developing and commercializing novel osteobiologic products based on a proprietary small peptide technology (P-15) on anorganic bone mineral (ABM), supported by the highest level of clinical evidence, and validated in clinically relevant real world applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glen Kashuba
Chief Financial Officer
Drew Trivisonno
Chief Operating Officer
Jeff Marx
VP - Bus. Development
Andrew Woods
VP - Marketing
Scott Johnson
VP - R & D
Jerome Connor
VP - Regulatory Affairs
Roger White
VP - Sales
Andrew Barnes
Browse more venture capital transactions:
Prev: 4/21/2017: SafeGraph venture capital transaction
Next: 4/21/2017: Invertex venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs